Stay updated with breaking news from Edwin Hardeman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court on Monday asked the Department of Justice to provide its view of a dispute between Monsanto, the company behind the herbicide Roundup, and a California man who successfully sued the agrochemical giant for causing his cancer.
Bayer in August filed a petition with the Supreme Court to reverse a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the German pharmaceutical and chemical giant's glyphosate-based weedkillers. The Supreme Court's decision on whether to take up the matter is being closely watched as Bayer maneuvers to limit its legal liability in thousands of cases.
Bayer in August filed a petition with the Supreme Court to reverse a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the German pharmaceutical and chemical giant's glyphosate-based weedkillers. The Supreme Court's decision on whether to take up the matter is being closely watched as Bayer maneuvers to limit its legal liability in thousands of cases.
Bayer in August filed a petition with the Supreme Court to reverse a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the German pharmaceutical and chemical giant's glyphosate-based weedkillers. The Supreme Court's decision on whether to take up the matter is being closely watched as Bayer maneuvers to limit its legal liability in thousands of cases.
Bayer in August filed a petition with the Supreme Court to reverse a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman, a Roundup user who blamed his cancer on the German pharmaceutical and chemical giant's glyphosate-based weedkillers. The Supreme Court's decision on whether to take up the matter is being closely watched as Bayer maneuvers to limit its legal liability in thousands of cases.